BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25629611)

  • 1. Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis.
    Nelson N; Xiang S; Zhang X; Gilvary D; Djeu J; Husain K; Malafa M; Vohra N; Pilon-Thomas S; Ghansah T
    PLoS One; 2015; 10(1):e0115546. PubMed ID: 25629611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer.
    Nelson N; Szekeres K; Iclozan C; Rivera IO; McGill A; Johnson G; Nwogu O; Ghansah T
    PLoS One; 2017; 12(2):e0170197. PubMed ID: 28152014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function.
    Pilon-Thomas S; Nelson N; Vohra N; Jerald M; Pendleton L; Szekeres K; Ghansah T
    PLoS One; 2011; 6(11):e27729. PubMed ID: 22132131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein phosphatase 1 (PP1) and Casein Kinase II (CK2) regulate Ikaros-mediated repression of TdT in thymocytes and T-cell leukemia.
    Wang H; Song C; Gurel Z; Song N; Ma J; Ouyang H; Lai L; Payne KJ; Dovat S
    Pediatr Blood Cancer; 2014 Dec; 61(12):2230-5. PubMed ID: 25214003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ikaros, CK2 kinase, and the road to leukemia.
    Dovat S; Song C; Payne KJ; Li Z
    Mol Cell Biochem; 2011 Oct; 356(1-2):201-7. PubMed ID: 21750978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1.
    Popescu M; Gurel Z; Ronni T; Song C; Hung KY; Payne KJ; Dovat S
    J Biol Chem; 2009 May; 284(20):13869-13880. PubMed ID: 19282287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.
    Gowda C; Song C; Kapadia M; Payne JL; Hu T; Ding Y; Dovat S
    Adv Biol Regul; 2017 Jan; 63():71-80. PubMed ID: 27666503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional Regulation of PIK3CD and PIKFYVE in T-Cell Acute Lymphoblastic Leukemia by IKAROS and Protein Kinase CK2.
    Dovat E; Song C; Hu T; Rahman MA; Dhanyamraju PK; Klink M; Bogush D; Soliman M; Kane S; McGrath M; Ding Y; Desai D; Sharma A; Gowda C
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of alkaline phosphatase activity by L-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros.
    Son E; Do H; Joo HM; Pyo S
    Nutrition; 2007 Oct; 23(10):745-53. PubMed ID: 17664058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.
    Wang H; Song C; Ding Y; Pan X; Ge Z; Tan BH; Gowda C; Sachdev M; Muthusami S; Ouyang H; Lai L; Francis OL; Morris CL; Abdel-Azim H; Dorsam G; Xiang M; Payne KJ; Dovat S
    J Biol Chem; 2016 Feb; 291(8):4004-18. PubMed ID: 26655717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Small GTPase Rab20 by Ikaros in B-Cell Acute Lymphoblastic Leukemia.
    Payne JL; Song C; Ding Y; Dhanyamraju PK; Bamme Y; Schramm JW; Desai D; Sharma A; Gowda C; Dovat S
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia.
    Song C; Gowda C; Pan X; Ding Y; Tong Y; Tan BH; Wang H; Muthusami S; Ge Z; Sachdev M; Amin SG; Desai D; Gowda K; Gowda R; Robertson GP; Schjerven H; Muschen M; Payne KJ; Dovat S
    Blood; 2015 Oct; 126(15):1813-22. PubMed ID: 26219304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein signaling and regulation of gene transcription in leukemia: role of the Casein Kinase II-Ikaros axis.
    Gowda CS; Song C; Ding Y; Kapadia M; Dovat S
    J Investig Med; 2016 Mar; 64(3):735-9. PubMed ID: 26912004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Casein Kinase II (CK2), Glycogen Synthase Kinase-3 (GSK-3) and Ikaros mediated regulation of leukemia.
    Gowda C; Soliman M; Kapadia M; Ding Y; Payne K; Dovat S
    Adv Biol Regul; 2017 Aug; 65():16-25. PubMed ID: 28623166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia.
    Song C; Ge Z; Ding Y; Tan BH; Desai D; Gowda K; Amin S; Gowda R; Robertson GP; Yue F; Huang S; Spiegelman V; Payne JL; Reeves ME; Gurel Z; Iyer S; Dhanyamraju PK; Xiang M; Kawasawa YI; Cury NM; Yunes JA; McGrath M; Schramm J; Su R; Yang Y; Zhao Z; Lyu X; Muschen M; Payne KJ; Gowda C; Dovat S
    Blood; 2020 Sep; 136(13):1520-1534. PubMed ID: 32396934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect of acrylamide on NCAM expression in human neuroblastoma cells: involvement of CK2/Ikaros signaling pathway.
    Lee HR; Cho SJ; Park HJ; Kim KH; Rhee DK; Pyo S
    Toxicol In Vitro; 2010 Oct; 24(7):1946-52. PubMed ID: 20708675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma.
    Liyanage UK; Goedegebuure PS; Moore TT; Viehl CT; Moo-Young TA; Larson JW; Frey DM; Ehlers JP; Eberlein TJ; Linehan DC
    J Immunother; 2006; 29(4):416-24. PubMed ID: 16799337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-Specific Phosphorylation of Ikaros Induced by Low-Dose Ionizing Radiation Regulates Cell Cycle Progression of B Lymphoblast Through CK2 and AKT Activation.
    Cho SJ; Kang H; Kim MY; Lee JE; Kim SJ; Nam SY; Kim JY; Kim HS; Pyo S; Yang KH
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1207-18. PubMed ID: 27026320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling pathways and regulation of gene expression in hematopoietic cells.
    Bogush D; Schramm J; Ding Y; He B; Singh C; Sharma A; Tukaramrao DB; Iyer S; Desai D; Nalesnik G; Hengst J; Bhalodia R; Gowda C; Dovat S
    Adv Biol Regul; 2023 May; 88():100942. PubMed ID: 36621151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Casein Kinase II (CK2) as a Therapeutic Target for Hematological Malignancies.
    Gowda C; Sachdev M; Muthusami S; Kapadia M; Petrovic-Dovat L; Hartman M; Ding Y; Song C; Payne JL; Tan BH; Dovat S
    Curr Pharm Des; 2017; 23(1):95-107. PubMed ID: 27719640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.